National Vaccine And Serum Institute, China

This study tests an experimental vaccine that targets 11 types of HPV, the virus that causes cervical cancer. About 13,500 Chinese women aged 18-45 will receive either the vaccine or a placebo over 6 months. The goal is to see if the vaccine prevents serious cervical cell changes…